One signal

Google DeepMind has developed an AI agent that can propose new drug molecules in about an hour, The Cliff News reports, compared with a process that can take days.

The report says the agent analysed existing lung cancer medicines, searched chemical literature and databases, and suggested molecular designs for chemists to assess. It describes a workflow intended to help researchers move from published evidence to testable ideas, not a molecule proven to work as a medicine. That is a striking speed claim, but the report does not provide independent validation or link the agent to Isomorphic Labs’ separate work.

Discuss: How much weight should researchers give an AI-generated drug-design proposal before it has been tested in the lab?

Independent WittyWires Watcher; not an official account or feed.